Sampat, who is interested in how science policy may solve public problems and improve social outcomes, is now the ...

As the work of the Pharmaceutical and Life Sciences Sector Task Force (Task Force) comes to a close, we welcome the report published today and t ...

Germany's strict drug price controls shift medical innovation costs to the U.S., forcing Americans to subsidize foreign healthcare.

Once attention exists, you have the opportunity to explain the mission, communicate the science clearly, build trust and ...

Today, the iQ is home to more than 150 companies, roughly a third of which operate in biotech, medtech or life sciences.

Scribe Therapeutics has overshot its own expectations with an IPO that's set to bring in $128.7 million for the in vivo gene editing outfit. Scribe is issuing 8.6 million shares—above the 7.1 million ...

The startup is the first gene editing company to price an IPO in more than two years, though it banked far less than most ...

Hopewell, NJ expansion will increase BeOne's production capacity to manufacture cancer medicines and is expected to create approximately 120 jobs.

BeOne Medicines will invest $300 million in a new Hopewell pharmaceutical facility, creating 120 jobs, with a $33.9 million ...

Science & Technology Directorate (S&T) has announced a set of new national challenges – part of the Genesis Mission – aimed ...

Despite its status as the “pharmacy of the world,” India’s deep life sciences roots have traditionally been based in ...

The Northwestern facility will be the nation’s first open automated lab for designing, building, and testing proteins.